CytoSorbents Q1 2024 GAAP EPS $(0.12), Inline, Sales $9.787M Beat $9.785M Estimate
CytoSorbents Q1 2024 GAAP EPS $(0.12), Inline, Sales $9.787M Beat $9.785M Estimate
CytoSorbents 2024年第一季度GAAP每股收益为0.12美元（0.12美元），直列式，销售额为978.7万美元，超过预期的978.5万美元
CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 29.41 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $9.787 million which beat the analyst consensus estimate of $9.785 million by 0.02 percent. This is a 3.58 percent increase over sales of $9.449 million the same period last year.
CytoSorbents（纳斯达克股票代码：CTSO）公布的季度亏损为每股0.12美元，符合分析师的共识预期。这比去年同期每股亏损0.17美元（0.17美元）增长了29.41％。该公司公布的季度销售额为978.7万美元，比分析师普遍预期的978.5万美元高出0.02％。这比去年同期的944.9万美元的销售额增长了3.58％。